SecBot SecBot
Insider Cluster (1 insider) ·Filed Mar 19, 2026

IBIO

iBio, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago
Insider cluster: 3 insiders, $0.1M total
Actionable Insight • Neutral

While the dollar amount is small and not immediately market-moving, the continued insider buying — especially by a C-suite officer — suggests confidence at a time when the company remains underfollowed and low-liquidity. Traders should monitor for additional purchases or catalysts such as clinical updates or partnerships.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
IBIO ▼ -19.52% at T+60d
NEUTRAL call -19.52% · α vs SPY -33.87% · entry $2.10 → $1.69
Entry = T+0 close
Mar 18, 2026
via day close
T+1d
-0.48%
call -0.48% · α +1.27%
$2.09
settled 7mo ago
T+5d
-17.14%
call -17.14% · α -14.93%
$1.74
settled 7mo ago
T+20d
-1.90%
call -1.90% · α -9.53%
$2.06
settled 6mo ago
T+60d
-19.52%
call -19.52% · α -33.87%
$1.69
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

iBio's Chief Legal Officer, Marc Banjak, purchased 12,500 shares in the open market for approximately $20,531, marking a small but notable insider buy. This adds to recent insider buying activity, with three other purchases totaling $96K in the past 30 days.

Key Financial Metrics

Direction
buying
Total Value
$20.5K
Insiders
1

Key Facts

  • Chief Legal Officer Marc Banjak purchased 12,500 shares at $1.6425 per share for a total of $20,531.25
  • This is an open-market purchase (Form 4 code 'P'), indicating direct confidence in the company
  • Total insider buying in the past 30 days now reaches $116,531
  • The transaction represents approximately 0.034% of the company's $60M market cap

Financial Impact

$20,531 in open-market purchases by a C-suite executive

insider ownershipmarket sentiment

Risk Factors

  • The transaction is minor in absolute and relative terms (<0.1% of market cap), limiting its significance
  • No accompanying financial or operational filing was provided, so no fundamental catalyst is evident

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (1 trades, 7d window)cluster-IBIO-1774641960079
16 reports for IBIO
Performance horizon
60% Hit rate @ T+5 3 of 5 directional calls Went positive at some point 3 of 5 best @ T+20▲ +36.43%Feb 27, 2026
Filters
Rows
Reports for IBIO — sortable, filterable
TypeNow
Oct 19, 2026
7d ago
8-K
NEUTRAL ★ 3/10
$0.8210awaiting T+5—$0.7100 (−13.52%)
Oct 14, 2026
12d ago
SC 13G
NEUTRAL ★ 4/10
$0.7808 $0.8400▲ +7.58%▲ +7.13%$0.7100 (−9.07%)
Oct 13, 2026
13d ago
8-K
BULLISH ★ 5/10
$0.7818 $0.8210▲ +5.01%▲ +6.17%$0.7100 (−9.18%)
Sep 14, 2026
6w ago
8-K
NEUTRAL ★ 4/10
$1.19 $1.33▲ +11.76%▲ +9.64%$0.7100 (−40.34%)
Aug 28, 2026
8w ago
8-K
NEUTRAL ★ 4/10
$1.36 $1.31▼ −3.68%▼ −3.79%$0.7100 (−47.79%)
Aug 28, 2026
8w ago
Press Release
NEUTRAL ★ 4/10
$1.36 $1.31▼ −3.68%▼ −3.79%$0.7100 (−47.79%)
Jul 1, 2026
16w ago
8-K
BULLISH ★ 6/10
$1.75 $1.59▼ −9.14%▼ −9.40%$0.7100 (−59.43%)
May 15, 2026
23w ago
3
NEUTRAL ★ 2/10
$1.47 $1.84▲ +25.17%▲ +24.21%$0.7100 (−51.70%)
May 12, 2026
23w ago
Press Release
BEARISH ★ 6/10
$1.55 $1.50▲ +3.23%▲ +2.07%$0.7100 (+54.19%)
May 8, 2026
24w ago
8-K
NEUTRAL ★ 2/10
$1.66 $1.42▼ −14.46%▼ −14.37%$0.7100 (−57.23%)
Showing 10 of 16

US Market Status

Market Closed — Opens in 1h 13m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 27, 2026